Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
Tóm tắt
PD-1 is an immunoinhibitory receptor expressed by activated T cells, B cells, and myeloid cells. Mice deficient in PD-1 exhibit a breakdown of peripheral tolerance and demonstrate multiple autoimmune features. We report here that the ligand of PD-1 (PD-L1) is a member of the B7 gene family. Engagement of PD-1 by PD-L1 leads to the inhibition of T cell receptor–mediated lymphocyte proliferation and cytokine secretion. In addition, PD-1 signaling can inhibit at least suboptimal levels of CD28-mediated costimulation. PD-L1 is expressed by antigen-presenting cells, including human peripheral blood monocytes stimulated with interferon γ, and activated human and murine dendritic cells. In addition, PD-L1 is expressed in nonlymphoid tissues such as heart and lung. The relative levels of inhibitory PD-L1 and costimulatory B7-1/B7-2 signals on antigen-presenting cells may determine the extent of T cell activation and consequently the threshold between tolerance and autoimmunity. PD-L1 expression on nonlymphoid tissues and its potential interaction with PD-1 may subsequently determine the extent of immune responses at sites of inflammation.
Từ khóa
Tài liệu tham khảo
Ishida, 1992, Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death, EMBO (Eur. Mol. Biol. Organ.) J., 11, 3887, 10.1002/j.1460-2075.1992.tb05481.x
Agata, 1996, Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes, Int. Immunol., 8, 765, 10.1093/intimm/8.5.765
Vibhakar, 1997, Activation-induced expression of human programmed death-1 gene in T-lymphocytes, Exp. Cell Res., 232, 25, 10.1006/excr.1997.3493
Shinohara, 1994, Structure and chromosomal localization of the human PD-1 gene (PDCD1), Genomics., 23, 704, 10.1006/geno.1994.1562
Vivier, 1997, Immunoreceptor tyrosine-based inhibition motifs, Immunol. Today., 18, 286, 10.1016/S0167-5699(97)80025-4
Nishimura, 1999, Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor, Immunity., 11, 141, 10.1016/S1074-7613(00)80089-8
Sperling, 1996, The complexities of T-cell costimulationCD28 and beyond, Immunol. Rev., 153, 155, 10.1111/j.1600-065X.1996.tb00924.x
Thompson, 1997, The emerging role of CTLA-4 as an immune attenuator, Immunity., 7, 445, 10.1016/S1074-7613(00)80366-0
Harper, 1991, CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location, J. Immunol., 147, 1037, 10.4049/jimmunol.147.3.1037
Freeman, 1998, The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counter receptor, J. Immunol., 161, 2708, 10.4049/jimmunol.161.6.2708
Ling, 2000, Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor, J. Immunol., 164, 1653, 10.4049/jimmunol.164.4.1653
Blair, 1998, CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-XL induction, J. Immunol., 160, 12, 10.4049/jimmunol.160.1.12
Byrne, 2000, Preparation of mRNA for expression monitoring, Current Protocols in Molecular Biology Supplement. Vol. 49, 22
Freeman, 1992, CTLA-4 and CD28 are coexpressed in most T-cells after activation, J. Immunol., 149, 3795, 10.4049/jimmunol.149.12.3795
Boussiotis, 1996, The role of B7-1/B7-2:CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response, Immunol. Rev., 153, 5, 10.1111/j.1600-065X.1996.tb00918.x
Dong, 1999, B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion, Nat. Med., 5, 1365, 10.1038/70932
Swallow, 1999, B7h, a novel costimulatory homolog of B7-1 and B7-2, is induced by TNFα, Immunity., 11, 423, 10.1016/S1074-7613(00)80117-X
Reeves, 1997, The costimulatory genes CD80 and CD86 are linked on mouse chromosome 16 and human chromosome 3, Mamm. Genome., 8, 581, 10.1007/s003359900508
Henry, 1999, Structure and evolution of the extended B7 family, Immunol. Today., 20, 285, 10.1016/S0167-5699(98)01418-2
Nishimura, 1998, Immunological studies on PD-1 deficient miceimplication of PD-1 as a negative regulator for B cell responses, Int. Immunol., 10, 1563, 10.1093/intimm/10.10.1563
Tivol, 1995, Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4, Immunity., 3, 541, 10.1016/1074-7613(95)90125-6
Waterhouse, 1995, Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4, Science., 270, 985, 10.1126/science.270.5238.985
Nickloff, 1993, Discordant expression of CD28 ligands, BB-1, and B7-1 on keratinocytes in vitro and psoriatic cells in vivo, Am. J. Pathology., 142, 1029
Suda, 1993, Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell., 75, 1169, 10.1016/0092-8674(93)90326-L
Ikemizu, 2000, Structure and dimerization of a soluble form of B7-1, Immunity., 12, 51, 10.1016/S1074-7613(00)80158-2
Fitz, 1997, Characterization of murine Flt4 ligand/VEGF-C, Oncogene., 15, 613, 10.1038/sj.onc.1201191